Cargando…

Non-alcoholic fatty liver disease and the risk of dementia: A meta-analysis of cohort studies

Detalles Bibliográficos
Autores principales:	Lu, Li-Yu, Wu, Min-You, Kao, Yung-Shuo, Hung, Cheng-Hsien
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association for the Study of the Liver 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597230/ https://www.ncbi.nlm.nih.gov/pubmed/36064305 http://dx.doi.org/10.3350/cmh.2022.0259

Ejemplares similares

Non-alcoholic fatty liver disease and risk of dementia: Unmet need for a pooled analysis of cohort studies
por: Jeong, Seogsong, et al.
Publicado: (2022)

Learning More About the Effects of Gamification on Physical Activity. Comment on “Evaluating the Effectiveness of Gamification on Physical Activity: Systematic Review and Meta-analysis of Randomized Controlled Trials”
por: Hung, Cheng-Hsien, et al.
Publicado: (2022)

Body Composition and Non-alcoholic Fatty Liver Disease
por: Abenavoli, Ludovico, et al.
Publicado: (2016)

Eyeing non-alcoholic fatty liver disease: The noninvasive way
por: Gude, Dilip
Publicado: (2011)

Silymarin: An option to treat non-alcoholic fatty liver disease
por: Colica, Carmela, et al.
Publicado: (2017)

Lean non-alcoholic fatty liver disease: do not forget diabetes
por: Patoulias, Dimitrios Ioannis, et al.
Publicado: (2019)

Noninvasive Imaging for the Evaluation of Non-Alcoholic Fatty Liver Disease Spectrum
por: Liu, Qianjiao, et al.
Publicado: (2021)

Non-alcoholic fatty liver disease, diabetes medications and blood pressure
por: Ilias, Ioannis, et al.
Publicado: (2021)

Letter regarding “Non-alcoholic fatty liver disease: Definition and subtypes”
por: Jeong, Seogsong, et al.
Publicado: (2023)

Multipronged Approach to Assess Risk Factors for Non-alcoholic Fatty Liver Disease
por: Hidrus, Aizuddin, et al.
Publicado: (2022)

Comments on Prevalence of Non-alcoholic Fatty Liver Disease and Its Related Factors in Iran
por: Karimi-Sari, H., et al.
Publicado: (2017)

Do artificial sweeteners increase the risk of non-alcoholic fatty liver disease (NAFLD)?
por: Abbas, Tahany, et al.
Publicado: (2020)

Assessing causal relationships between COVID-19 and non-alcoholic fatty liver disease
por: Liu, Dong, et al.
Publicado: (2022)

Serum leptin in non-alcoholic fatty liver disease: Ambiguous clinical implications concerning cardiovascular disease
por: Patoulias, Dimitrios, et al.
Publicado: (2019)

Liraglutide for non-alcoholic fatty liver disease in children and adolescents: has a new era arrived?
por: Patoulias, Dimitrios Ioannis
Publicado: (2019)

Lean non-alcoholic fatty liver disease: Is there a place for novel antidiabetics in the therapeutic management of this underappreciated “enemy”?
por: Patoulias, Dimitrios, et al.
Publicado: (2020)

Non-alcoholic fatty liver disease in patients with inflammatory bowel disease might boost cardiovascular disease burden
por: Patoulias, Dimitrios Ioannis
Publicado: (2019)

Non-alcoholic fatty liver disease associated with greater herpes zoster risk than alcoholic fatty liver disease
por: Yu, Cheng-Wei, et al.
Publicado: (2023)

Empagliflozin promises to bridge the gap between non-alcoholic fatty liver disease, type 2 diabetes, and cardiovascular disease
por: Patoulias, Dimitrios, et al.
Publicado: (2018)

Dementia and non-alcoholic fatty liver disease – An unprecedented relationship
por: Latif, Fakhar, et al.
Publicado: (2022)

Letter regarding “The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults”
por: Lee, Hye Won
Publicado: (2023)

Is Ki-67 a prognostic factor for post-operation survival in patients with non-alcoholic fatty liver disease-associated hepatocellular carcinoma?
por: Li, Changcan, et al.
Publicado: (2022)

Correspondence on Letter regarding “The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults”
por: Lee, Jun-Hyuk, et al.
Publicado: (2023)

Non-alcoholic fatty liver disease may be associated with endothelial dysfunction
por: Balta, Sevket, et al.
Publicado: (2014)

Endothelial dysfunction and carotid atherosclerosis in non-alcoholic fatty liver disease
por: Dogru, Teoman, et al.
Publicado: (2014)

A proteo-transcriptomic map of non-alcoholic fatty liver disease signatures
por: Govaere, Olivier, et al.
Publicado: (2023)

Prostate Cancer and Cardiovascular Risk Factors
por: Lin, Cha-An, et al.
Publicado: (2023)

Urinary lithogenic profile of patients with non-alcoholic fatty liver disease
por: Bargagli, Matteo, et al.
Publicado: (2023)

Risk of dementia or cognitive impairment in non-alcoholic fatty liver disease: A systematic review and meta-analysis
por: Wang, Luping, et al.
Publicado: (2022)

Acute Fatty Liver of Pregnancy
por: Dey, Madhusudan, et al.
Publicado: (2012)

Cohort profile: the Trivandrum non-alcoholic fatty liver disease (NAFLD) cohort
por: Chalmers, Jane, et al.
Publicado: (2019)

More on Current Evidences on Probiotics as a Novel Treatment for Non-Alcoholic Fatty Liver Disease
por: Vajro, Pietro, et al.
Publicado: (2013)

Association of non-alcoholic fatty liver disease with incident dementia later in life among elder adults
por: Jeong, Seogsong, et al.
Publicado: (2022)

Effect of Intermittent Fasting on Non-Alcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis
por: Yin, Cong, et al.
Publicado: (2021)

Mechanism of CD38 via NAD(+) in the Development of Non-alcoholic Fatty Liver Disease
por: Dong, Min, et al.
Publicado: (2023)

Intestinal virome: An important research direction for alcoholic and nonalcoholic liver diseases
por: Li, Yan, et al.
Publicado: (2022)

Site-specific risk of colorectal neoplasms in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis
por: Lin, XiaoLi, et al.
Publicado: (2021)

Management of Dyslipidemia in Patients with Non-Alcoholic Fatty Liver Disease
por: Martin, Anna, et al.
Publicado: (2022)

Comments on Relationship between the High Fatty Liver Index and Risk of Fracture: Reply
por: Kim, Min-Ji, et al.
Publicado: (2023)

Reply to: ‘No evidence for an increased liver uptake of SARS-CoV-2 in metabolic-associated fatty liver disease’
por: Ji, Dong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2li8fmnnoa0imrl7dbgnad77mj